Company intelligence
European Association for the Study of Diabetes e.V. (EASD)
We promote excellence in diabetes care through research, networking and education.
About European Association for the Study of Diabetes e.V. (EASD)
The European Association for the Study of Diabetes (EASD) e.V. is a membership-based non-profit organisation with the mission to promote excellence in diabetes care through research, networking, and education. The EASD Annual Meeting is one of the largest diabetes conferences in the world, attracting thousands of delegates each year. EASD is a leader in education for healthcare professionals and develops statements and guidelines that translate the latest research into best practices in diabetes management. The Association publishes Diabetologia, a major monthly international journal with an impact factor of 10.2 (2024), and Metabologia, an international, peer-reviewed, open-access journal. In 2000, EASD reinforced its commitment to European diabetes research by creating the European Foundation for the Study of Diabetes (EFSD), which has since committed over €130 million to research. For more information, please visit: www.easd.org
Verified activity
Signals from European Association for the Study of Diabetes e.V. (EASD)
9 published signals
Research & Knowledge
European Association for the Study of Diabetes e.V. (EASD) Associate Prof. Pia Nyeng published a research paper exploring whether pancreatic neurons guide pancreatic organogenesis and beta cell formation during development.
Reported by European Association for the Study of Diabetes e.V. (EASD)
Presence & Recognition
European Association for the Study of Diabetes e.V. (EASD) announced that Prof. Daisuke Yabe will present his first-in-human case on allogeneic transplantation of human induced pluripotent stem cell-derived islet cells at the EASD Annual Meeting 2026 in Milan on Friday, 2 October 2026.
Reported by European Association for the Study of Diabetes e.V. (EASD)
Presence & Recognition
European Association for the Study of Diabetes e.V. (EASD) hosted a satellite session enriching the EASD 2026 programme featuring the Psychosocial Aspects of Diabetes (PSAD) Study Group symposium on Thursday, October 1, 2026, at Berlin Hall.
Reported by European Association for the Study of Diabetes e.V. (EASD)
Research & Knowledge
European Association for the Study of Diabetes e.V. (EASD) published the results of the SURPASS-PEDS trial, which evaluated the dual GIP/GLP-1 receptor agonist tirzepatide in adolescents with type 2 diabetes.
Reported by European Association for the Study of Diabetes e.V. (EASD)
Presence & Recognition
European Association for the Study of Diabetes e.V. (EASD) is hosting the EASD Annual Meeting 2026 in Milan on Thursday, 1 October 2026, featuring Prof. Tomasz Klupa presenting on the human factor and patients at the center of closed-loop systems.
Reported by European Association for the Study of Diabetes e.V. (EASD)
Presence & Recognition
European Association for the Study of Diabetes e.V. (EASD) hosted an e-Learning Expert Insights episode featuring Prof. Pratik Choudhary discussing hybrid and emerging fully closed-loop systems in type 1 and insulin-requiring type 2 diabetes.
Reported by European Association for the Study of Diabetes e.V. (EASD)
Research & Knowledge
European Association for the Study of Diabetes e.V. (EASD) published a study by Prof. Oluf Pedersen on the effects of RORDEP1, a bioactive hormone produced by gut bacteria, in healthy individuals.
Reported by European Association for the Study of Diabetes e.V. (EASD)
People
European Association for the Study of Diabetes e.V. (EASD) is open for applications for the Albert Renold Travel Fellowship, which offers up to €10,000 in research stays for up to 3 months.
Reported by European Association for the Study of Diabetes e.V. (EASD)
Presence & Recognition
European Association for the Study of Diabetes e.V. (EASD) received a shoutout from 10eG visual GmbH for the upcoming 2027 event.
Reported by Nomcebo Jele